Gulf Resources, Inc. — Q3 2021 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2021. The unaudited statements consolidate the company’s China-based subsidiaries. Gulf Resources produces bromine and crude salt; chemical-product operations remain closed, and natural-gas production is suspended pending approvals.
Financial performance
| Metric | Q3 2021 | Q3 2020 | Nine months 2021 | Nine months 2020 |
|---|---|---|---|---|
| Revenue | $17.75 million | $10.48 million | $34.16 million | $16.40 million |
| Gross profit / margin | $9.56 million / 54% | $3.73 million / 36% | $14.87 million / 44% | $3.71 million / 23% |
| Operating income (loss) | $7.10 million | $(2.73) million | $1.43 million | $(10.52) million |
| Net income (loss) | $5.39 million | $(2.91) million | $0.19 million | $(8.70) million |
| Basic and diluted EPS | $0.52 | $(0.30) | $0.02 | $(0.91) |
| Operating cash flow | Not presented separately | Not presented separately | $11.06 million | $3.26 million |
- Q3 revenue rose 69%; bromine revenue increased 62% and crude salt revenue 118%. Management attributed growth to higher selling prices and volumes. Nine-month revenue more than doubled, with bromine up 110% and crude salt up 95%.
- Q3 gross margin improved to 54%, reflecting stronger segment margins: bromine 56% versus 39%, and crude salt 44% versus 9% a year earlier. Nine-month gross margin was 44% versus 23%.
- Q3 operating results turned profitable, aided by higher gross profit and general and administrative expense falling to $1.21 million from $4.91 million. Nine-month G&A rose 12% to $8.15 million.
- Nine-month net income was modest despite positive operating income; the company reported a $1.36 million income tax expense, compared with a $1.71 million tax benefit in the prior-year period. Q3 included a $1.75 million tax benefit.
Financial position and liquidity
- At September 30, 2021, cash was $98.88 million, total current assets $117.92 million, and current liabilities $13.12 million. Working capital was approximately $104.80 million; the current ratio was approximately 9.0.
- Total assets were $304.44 million and stockholders’ equity $282.22 million. Total liabilities were $22.22 million, including approximately $9.76 million of finance and operating lease liabilities; the filing reports no conventional borrowings.
- Nine-month operating cash flow of $11.06 million and exchange-rate effects of $2.45 million, less $8.56 million of capital spending and $0.29 million of finance-lease repayments, contributed to a $4.66 million increase in cash.
- Accounts receivable rose $6.91 million from year-end to $13.43 million; all reported receivables were aged 90 days or less. The company recorded no doubtful-account allowance. Cash is held with PRC financial institutions and is not insured or otherwise protected, according to the filing.
- Capital expenditures for the nine months were $8.56 million. The company reported $11.06 million in capital expenditure commitments, including $10.30 million payable within 12 months. Management said available funds and operating cash flows should cover anticipated needs and obligations over the next year.
Material changes, outlook, and risks
- Operating improvement was principally associated with bromine and crude salt; these products accounted for all revenue in the periods presented. Chemical products and natural gas each generated no revenue.
- Only bromine factories No. 1, 4, 7 and 9 had approval to operate; factories No. 2, 8 and 10 remained subject to government approvals. The nine-month bromine capacity-utilization ratio was 23%, unchanged year over year.
- The new chemical factory’s civil works were substantially complete, but equipment delivery, installation, testing, and trial production were delayed by supply-chain disruption and electricity restrictions in China. The company could not estimate the extent of the delay. Its relocation project is estimated to cost approximately $64 million; $43.57 million had been recorded in prepaid land leases and property, plant and equipment at September 30.
- In an October 20, 2021 update, management said bromine prices had risen sharply and expected the price-cost relationship to benefit Q4 2021 profitability. It could not predict how long supply shortages or elevated prices would persist. This is commentary, not quantified formal guidance.
- Regulatory and land-use matters remain significant: administrative decisions and court rulings concern alleged unauthorized land use at several factories and include orders for land return and possible demolition or confiscation, plus penalties totaling approximately RMB 1.3 million ($184,000). The company considers enforcement and material losses remote and recorded no accrual, but warns further action could cause liabilities, penalties, or operational disruption.
- Three customers accounted for approximately 63% of Q3 revenue; the top five customers represented 76.9% of nine-month sales. The top five suppliers provided all raw materials. Other disclosed risks include COVID-19 uncertainty, dependence on PRC operations and approvals, and potential delays to projects. Management reported disclosure controls were effective and no material quarterly change in internal control over financial reporting.
Most important facts for investors to verify
- Whether elevated bromine prices and improved margins persist, and how much Q4 earnings depend on them.
- Collections and credit quality for the $13.43 million receivable balance, including exposure to major customers.
- Timing, remaining costs, and required approvals for the new chemical factory and the three bromine factories still awaiting approval.
- Progress and potential financial or operating consequences of the land-use enforcement matters.
- Ability to fund the chemical relocation and other committed spending while maintaining cash held in PRC institutions.